Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL732071 | 0.91 | TSHR (0.46) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL17450073 | 0.86 | TP53 (0.37) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL13033290 | 0.86 | TSHR (0.36) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL14415209 | 0.86 | TSHR (0.36) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL7876608 | 0.86 | TSHR (0.46) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL17085515 | 0.85 | TSHR (0.44) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL7079859 | 0.85 | TSHR (0.44) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL24465366 | 0.84 | CA2 (0.47) | TSHRTP53CYP3A4ALDH1A1LMNA | |
| SCHEMBL472962 | 0.84 | TSHR (0.44) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 | |
| SCHEMBL3237384 | 0.84 | TSHR (0.44) | TSHRTP53CYP3A4SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113881025-B | Branched polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-113881025-A | Branched polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-01-04 | — | — | CN | claimed |
| US-8911976-B2 | Lignin-based enzyme stabilizer | FORESTRY AND FOREST PRODUCTS RESEARCH INSTITUTE (JP) | 2014-12-16 | — | — | US | claimed |
| US-7913857-B2 | Polyamide overcoated with a crosslinked epoxy resin and a hydrophilic compound, being covalently bonded to the polyamide membrane; reverse osmosis membrane; water insolubility; permselectivity | WOONGJIN CHEMICAL CO., LTD. (KR) | 2011-03-29 | — | — | US | claimed |
| EP-2140929-A1 | Selective membrane having a high fouling resistance and preparation method thereof | Woongjin Chemical Co., Ltd. (KR) | 2010-01-06 | — | — | EP | claimed |
| US-20070175821-A1 | Selective membrane having a high fouling resistance | TORAY ADVANCED MATERIALS KOREA INC, (KR) | 2007-08-02 | — | — | US | claimed |
| EP-4682184-A1 | CURABLE EPOXY RESIN COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | DAIKIN INDUSTRIES, LTD. (JP) | 2026-01-21 | — | — | EP | disclosed |
| CN-113881025-B | Branched polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| US-20230187208-A1 | PROTECTIVE FILM-FORMING COMPOSITION CONTAINING DIOL STRUCTURE | NISSAN CHEMICAL CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| US-20230187208-A1 | PROTECTIVE FILM-FORMING COMPOSITION CONTAINING DIOL STRUCTURE | NISSAN CHEMICAL CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| CN-113881025-A | Branched polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-01-04 | — | — | CN | disclosed |
| EP-2123695-B1 | METAL THIETANE COMPOUND, POLYMERIZABLE COMPOSITION COMPRISING THE COMPOUND, RESIN, AND USE OF THE RESIN | MITSUI CHEMICALS INC (JP) | 2021-06-23 | — | — | EP | disclosed |
| EP-2698391-B1 | SELF-CROSSLINKABLE POLYSILOXANE-MODIFIED POLYHYDROXY POLYURETHANE RESIN, PROCESS FOR PRODUCING SAID RESIN, RESIN MATERIAL COMPRISING SAID RESIN, AND ARTIFICIAL LEATHER PRODUCED UTILIZING SAID RESIN | DAINICHISEIKA COLOR CHEM (JP) | 2018-06-13 | — | — | EP | disclosed |
| EP-1940992-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2008-07-09 | — | — | EP | disclosed |
| US-20070175821-A1 | Selective membrane having a high fouling resistance | TORAY ADVANCED MATERIALS KOREA INC, (KR) | 2007-08-02 | — | — | US | disclosed |
| US-20070112100-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY, LP | 2007-05-17 | — | — | US | disclosed |
| WO-2007022217-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2007-02-22 | — | — | WO | disclosed |
| US-7132501-B2 | Polymerizable composition containing novel cyclic sulfur compound and resin obtained by curing the polymerizable composition | MITSUI CHEMICALS, INC. (JP) | 2006-11-07 | — | — | US | disclosed |
| US-20050215757-A1 | Polymerizable composition containing novel cyclic sulfur compound and resin obtained by curing the polymerizable composition | MITSUI CHEMICALS, INC. (JP) | 2005-09-29 | — | — | US | disclosed |
| EP-1482002-A1 | POLYMERIZABLE COMPOSITION CONTAINING NOVEL CYCLIC SULFUR COMPOUND AND RESIN OBTAINED BY CURING THE POLYMERIZABLE COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2004-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230187208-A1 | PROTECTIVE FILM-FORMING COMPOSITION CONTAINING DIOL STRUCTURE | DSG1, RAD51, CDH1 | TSHR 4132/4885TP53 1171/4885CYP3A4 2552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.